CINECA IRIS Institutional Research Information System

SALVATORE, LISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.556
AS - Asia 612
EU - Europa 562
SA - Sud America 85
AF - Africa 49
OC - Oceania 1
Totale 2.865
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.518
SG - Singapore 243
CN - Cina 175
IT - Italia 139
DE - Germania 120
HK - Hong Kong 94
SE - Svezia 73
BR - Brasile 71
BG - Bulgaria 46
VN - Vietnam 38
FR - Francia 36
GB - Regno Unito 36
CA - Canada 33
RU - Federazione Russa 28
AT - Austria 24
FI - Finlandia 21
SN - Senegal 18
CI - Costa d'Avorio 13
TR - Turchia 12
IN - India 10
NG - Nigeria 10
NL - Olanda 8
BD - Bangladesh 7
ID - Indonesia 5
MX - Messico 5
UA - Ucraina 5
EC - Ecuador 4
JP - Giappone 4
AR - Argentina 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IE - Irlanda 3
IL - Israele 3
IQ - Iraq 3
VE - Venezuela 3
ZA - Sudafrica 3
CH - Svizzera 2
ES - Italia 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
PL - Polonia 2
PT - Portogallo 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BJ - Benin 1
CO - Colombia 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KR - Corea 1
LK - Sri Lanka 1
MN - Mongolia 1
NP - Nepal 1
PK - Pakistan 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
RW - Ruanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
Totale 2.865
Salva come PNG Salva come JPEG
Città #
Woodbridge 231
Ashburn 191
Fairfield 149
Singapore 149
Santa Clara 110
Hong Kong 91
Chandler 80
Seattle 73
Houston 70
Cambridge 59
Boardman 52
Ann Arbor 51
Shanghai 49
Wilmington 48
Sofia 46
Beijing 42
New York 37
Dallas 33
Pisa 27
Princeton 23
Vienna 20
Ottawa 19
Dakar 18
Lawrence 18
Des Moines 17
Medford 16
Los Angeles 15
Bremen 14
Düsseldorf 14
London 14
Abidjan 13
Dong Ket 13
Florence 13
Dearborn 12
Marseille 12
Munich 12
Buffalo 10
Frankfurt am Main 10
Istanbul 10
Lagos 10
Rome 10
Phoenix 9
Redwood City 9
Helsinki 8
Nuremberg 8
Nanjing 7
São Paulo 7
Toronto 7
Turin 7
Guangzhou 6
Lancaster 6
Seacroft 6
Serra 6
Changsha 5
Kunming 5
Milan 5
Positano 5
Redondo Beach 5
San Diego 5
San Francisco 5
Boulder 4
Brooklyn 4
Ho Chi Minh City 4
Lusciano 4
Montreal 4
Polverigi 4
Shenyang 4
Tianjin 4
Brasília 3
Curitiba 3
Dublin 3
Hebei 3
Leawood 3
Nürnberg 3
Paris 3
Rio de Janeiro 3
Stockholm 3
Tokyo 3
Turku 3
Vũng Tàu 3
Amsterdam 2
Atlanta 2
Belo Horizonte 2
Boston 2
Bắc Ninh 2
Cascina 2
Chicago 2
Dhaka 2
Genoa 2
Guarulhos 2
Guayaquil 2
Haifa 2
Hangzhou 2
Hanoi 2
Hortolândia 2
Johannesburg 2
Kuala Lumpur 2
Lecce 2
Mexico City 2
Montevideo 2
Totale 2.130
Salva come PNG Salva come JPEG
Nome #
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer 214
TRIBE-2: A phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group 197
An interview with Alfredo Falcone and Lisa Salvatore: RECOURSE and trifluridine/tipiracil in metastatic colorectal cancer 176
TAS-102 for the treatment of metastatic colorectal cancer 171
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer 159
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 151
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer 149
TRIPLETE: A randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer 144
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial 143
Location of primary tumor and benefit from anti-epidermal growth factorreceptor monoclonalantibodies in patients with RAS and BRAF wild-typemetastatic colorectal cancer 141
KRAS status and risk of venous thromboembolic events in patients with metastatic colorectal cancer: a case-control study. 138
Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial. 134
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer 121
Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer 115
Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib 112
null 98
Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study 88
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer 85
null 85
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer 68
First-line chemotherapy for mCRC-a review and evidence-based algorithm 68
Liver metastases do not predict resistance to the addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab in proficient MMR metastatic colorectal cancer: a secondary analysis of the AtezoTRIBE study 60
Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study 60
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract Cancers 42
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials 10
Totale 2.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.189
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021113 0 0 0 0 0 5 9 6 40 11 19 23
2021/2022214 3 9 2 3 34 36 4 5 19 13 9 77
2022/2023302 24 48 20 34 31 35 2 14 72 2 18 2
2023/2024160 13 11 24 6 20 27 14 13 4 2 7 19
2024/2025672 5 21 39 26 90 75 38 29 55 99 65 130
2025/2026466 61 78 47 49 137 94 0 0 0 0 0 0
Totale 2.929